Results 211 to 220 of about 65,998 (238)

Nivolumab

Reactions Weekly, 2021
openaire   +1 more source

Nivolumab

Reactions Weekly, 2020
  +6 more sources

Ipilimumab/nivolumab/nivolumab

Reactions Weekly
  +4 more sources

Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancer

Annals of Oncology, 2021
Hye Ryun Kim, J -H Kang, C-T Yang
exaly  

Nivolumab

Reactions Weekly, 2018
  +5 more sources

Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort

Journal of Thoracic Oncology, 2020
VÍCTOR Moreno, Matthew Hellmann, Scott Antonia   +2 more
exaly  

The impact of body composition parameters on severe toxicity of nivolumab

European Journal of Cancer, 2020
Jérôme Alexandre, Marie Wislez, Laure Hirsch   +2 more
exaly  

Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab

Cell, 2017
Jonathan Schneck, Thomas Gajewski, Rajarsi Mandal   +2 more
exaly  

Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer

Cancer Cell, 2018
Joseph D Szustakowski, Naiyer A Rizvi, Matthew Hellmann   +2 more
exaly  

Ipilimumab/nivolumab/Nivolumab/Nivolumab/relatlimab

Reactions Weekly
openaire   +1 more source